PRESTRELSKI STEVEN
SEC CIK 1744027 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| XERS | Xeris Biopharma Holdings, Inc. | CSO | 719.8K | — | $27.2K | 5 | 2021-10-05 | 2023-01-31 |
Most active insiders at XERS, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Hecht Beth | See Remarks | — | $1.31M |
| 2 | McCulloch Kevin | See Remarks | — | $1.09M |
| 3 | JOHNSON JOHN | Dir | — | $1.07M |
| 4 | Pieper Steven | See Remarks | — | $468.2K |
| 5 | Shannon John Patrick Jr | See Remarks, Dir | — | $349.7K |
| 6 | BORMANN-KENNEDY BARBARA-JEAN ANNE | Dir | — | $203.9K |
| 7 | HALKUFF DAWN | Dir | — | $121.9K |
| 8 | PERSKY MARLA | Dir | — | $91.4K |
| 9 | Brady James Aloysius | Dir | — | $60.0K |
| 10 | Nguyen Anh Tu | See Remarks | — | — |
PRESTRELSKI STEVEN made no open-market trades at XERS in the last 12 months.
Transactions 5
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-02-01 | 2023-01-31 | XERS | Xeris Biopharma Holdings, Inc. | PRESTRELSKI STEVEN | CSO | A - Grant | $0.00 | +150.0K | 719.8K | +26% | $0 | |
| D | 2022-02-24 | 2022-02-22 | XERS | Xeris Biopharma Holdings, Inc. | PRESTRELSKI STEVEN | CSO | M - OptEx | $0.69 | +11.2K | 581.0K | +2% | +$7,747 |
| D | 2022-02-24 | 2022-02-22 | XERS | Xeris Biopharma Holdings, Inc. | PRESTRELSKI STEVEN | CSO | S - Sale+OE | $2.42 | -11.2K | 569.8K | -2% | -$27.2K |
| 2022-01-05 | 2022-01-03 | XERS | Xeris Biopharma Holdings, Inc. | PRESTRELSKI STEVEN | CSO | A - Grant | $0.00 | +75.0K | 569.8K | +15% | $0 | |
| DM | 2021-10-05 | 2021-10-05 | XERS | Xeris Biopharma Holdings, Inc. | PRESTRELSKI STEVEN | CSO | A - Grant | — | +494.8K | 494.8K | New | — |
Purchase Sale Sale after option exercise All abbreviations